Americans experience insomnia symptoms
Have a clinically significant insomnia disorder
With an insomnia history, receive standard Table B ratings
Face decline based on insomnia alone
How Insomnia Affects Life Insurance Underwriting
Key insight: Insomnia is recognized as a common health condition that, in isolation, does not significantly increase mortality risk. Underwriting evaluates whether your insomnia indicates an underlying untreated condition or comorbid health issue that does affect mortality.
Life insurance underwriters evaluate applicants based on mortality risk. Insomnia itselfādifficulty falling asleep, staying asleep, or experiencing non-restorative sleepāis not classified as a mortality risk factor when it exists in isolation and isn’t causing measurable health consequences.
However, insomnia frequently occurs alongside conditions that do increase mortality risk: untreated sleep apnea, uncontrolled anxiety, depression, high blood pressure, cardiovascular disease, and metabolic disorders. Underwriters investigate whether your insomnia is primary (idiopathic) or secondary (caused by another condition).
The critical distinction: undiagnosed insomnia that might mask sleep apnea creates real underwriting risk. Diagnosed, evaluated, and insomnia with sleep apnea ruled out typically receives a minimal underwriting penalty.
Favorable Underwriting Profile
- Diagnosed with primary insomnia (not secondary to another condition)
- Sleep apnea was evaluated and ruled out via a sleep study
- Consistent, well-maintained sleep schedule despite difficulties
- Non-psychiatric cause (lifestyle, adjustment-related, or idiopathic)
- Good response to behavioral treatment or low-dose medication
- No comorbid untreated mental health or medical conditions
- Medication stable for 6+ months with good tolerance
Expected Rating: Standard or Table A
Moderate Complexity Profile
- Insomnia with managed anxiety or depression
- Sleep apnea diagnosed and treatment-compliant
- Multiple failed medication trials before the current stable regimen
- Insomnia secondary to a medical condition (thyroid, pain, etc.)
- Recent sleep study with documented results
- Working with a sleep specialist or therapist
Expected Rating: Table A-C
Higher-Risk or Postponed Profile
- Undiagnosed insomnia (no sleep study performed)
- Suspected sleep apnea symptoms, but not evaluated
- Insomnia withanĀ uncontrolled psychiatric condition
- Sleep apnea diagnosed, but refusing or non-compliant with treatment
- Multiple medications at high doses with poor control
- Insomnia is causing significant daytime impairment
- Recent medication changes or unstable regimen
Expected Rating: Table C-F or postponement
Professional Insight
“The insomnia cases we see get declined aren’t declined because of insomniaāthey’re declined because the applicant either has untreated sleep apnea or has an unmanaged underlying mental health condition. When someone with primary insomnia comes in with a recent normal sleep study proving no apnea, with stable sleep medication, and good overall health, they get standard rates. The person who hasn’t had a sleep study but reports severe sleep apnea symptoms faces real underwriting problems because that apnea could be significantly shortening their lifespan.”
– InsuranceBrokers USA – Management Team
The takeaway: insomnia doesn’t automatically increase your rates or disqualify you. What matters is: (1) have you been evaluated to rule out sleep apnea? (2) Are any underlying mental health or medical conditions being managed? (3) Is your current treatment stable and working? When these questions have positive answers, most people with a history of insomnia receive standard rates.
Insomnia vs. Sleep Apnea: The Critical Distinction
Key insight: Underwriters distinguish sharply between primary insomnia (difficulty sleeping) and sleep apnea (breathing interruptions during sleep). Sleep apnea significantly increases mortality risk; insomnia alone does not. The absence of a documented sleep study is the biggest underwriting red flag.
This distinction is absolutely critical to understanding insomnia underwriting. Many peopleāand unfortunately some medical professionalsāconflate insomnia with sleep apnea. They are different conditions with different mortality implications.
Primary Insomnia: Difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite adequate opportunity to sleep. No breathing interruptions. Sleep quality is poor, but airflow continues. Underwriting concern is low unless secondary to an untreated condition.
Sleep Apnea: Brief interruptions in breathing during sleep caused by airway collapse (obstructive), inadequate respiratory effort (central), or a combination. Each apneic event causes oxygen desaturation. Repeated cycles throughout the night create cardiovascular stress, increase blood pressure, accelerate atherosclerosis, and increase the risk of sudden cardiac death. Sleep apnea significantly increases mortality if untreated.
This distinction fundamentally changes the underwriting approach.
Sleep Apnea Red Flags in Underwriting
ā ļø Underwriters Request Sleep Studies When Applicants Report:
- Witnessed apneic episodes: Partner reports seeing you stop breathing or gasping during sleep
- Excessive daytime sleepiness: Falling asleep involuntarily during the day despite nighttime sleep
- Loud snoring: Particularly if intermittent or associated with gasping
- Morning headaches: Associated with poor sleep quality and oxygen desaturation
- Nocturia: Repeated awakening to urinate (can indicate apnea-induced arousals)
- High-risk demographics: Overweight, male, age 50+, family history of apnea
If any of these apply to you and you haven’t had a sleep study, expect underwriters to request one. Delaying this evaluation creates postponement risk.
Sleep Study Results and Underwriting Impact
| Sleep Study Result | Apnea-Hypopnea Index (AHI) | Underwriting Approach | Typical Rating Impact |
|---|---|---|---|
| Normal/No Apnea | AHI 0-5 events/hour | Insomnia is classified as primary; minimal underwriting concern | Standard to Table A |
| Mild Apnea | AHI 5-15 events/hour | Apnea diagnosed; compliance with CPAP/BiPAP critical | Table A-C if compliant; C-E if non-compliant |
| Moderate Apnea | AHI 15-30 events/hour | Significant treatment requirement; compliance documentation essential | Table B-D is fully compliant; postponement if not |
| Severe Apnea | AHI 30+ events/hour | Major underwriting concern; substantial compliance verification needed | Table D-H if compliant; decline if untreated |
| No Sleep Study Performed | Unknown | High-risk scenario; underwriters assume possible undiagnosed apnea | Typically, postponement until the study is completed |
Critical Point: The Missing Sleep Study
If you report insomnia symptoms but have never had a sleep study, underwriters will likely:
- Request one before making an underwriting decision (if you have any sleep apnea risk factors)
- Postpone your application pending completion of the sleep study
- Potentially decline if symptoms are significant and apnea hasn’t been ruled out
The solution is straightforward: have a sleep study performed before applying for insurance, or be prepared for application postponement. A normal sleep study is one of the most underwriting-friendly documents you can provide for insomnia cases.
Underlying Health Conditions and Insomnia
Key insight: Insomnia caused by or occurring alongside untreated mental health conditions or uncontrolled medical conditions significantly impacts underwriting. The underlying condition, not insomnia per se, drives the underwriting decision.
Secondary insomniaāinsomnia caused by another conditionārepresents the majority of clinical insomnia cases. Identifying and managing the underlying condition is critical for both health and insurance underwriting purposes.
Insomnia and Mental Health Conditions
Anxiety and Insomnia
- Strong bidirectional relationship (anxiety causes insomnia; insomnia worsens anxiety)
- Underwriting concern: uncontrolled anxiety, not insomnia itself
- Favorable scenario: Anxiety managed with therapy and/or medication; sleep improves with anxiety treatment
- Poor scenario: Uncontrolled anxiety despite treatment; escalating sleep medication needs
Depression and Insomnia
- Insomnia is a diagnostic feature of depression, not a separate problem
- Underwriting focus: depression stability and treatment response
- Favorable scenario: Depression in remission or well-managed; sleep normalizing with antidepressant therapy
- Poor scenario: Treatment-resistant depression with ongoing sleep disruption
See our depression underwriting guide.
Insomnia and Medical Conditions
| Medical Condition | Insomnia Connection | Underwriting Approach | Insurance Impact |
|---|---|---|---|
| High Blood Pressure | Both cause and consequence of poor sleep; sleep deprivation elevates BP | Primary focus on BP control; insomnia is a secondary concern | Depends on BP management, not insomnia status |
| Diabetes | Glucose instability disrupts sleep; poor sleep worsens glycemic control | Primary focus on glucose control; sleep management is part of the overall strategy | Depends on diabetes control, not sleep per se |
| Chronic Pain Conditions | Pain directly prevents sleep; poor sleep lowers pain threshold (cycle) | Primary focus on pain conditions and management | Depends on the underlying pain condition underwriting |
| COPD or Asthma | Nighttime breathing difficulty; medication timing affects sleep | Focus on respiratory disease control; insomnia managed as a symptom | Depends on lung disease severity, not insomnia rating |
| Thyroid Dysfunction | Hyperthyroidism causes racing thoughts/insomnia; hypothyroidism causes fatigue | Primary focus on thyroid hormone optimization | Typically resolves with proper thyroid management; minimal rate impact |
ā ļø Red Flags: Untreated Underlying Conditions
Underwriters view these scenarios unfavorably:
- Insomnia diagnosis without investigation for sleep apnea
- Insomnia with a known untreated mental health condition
- Escalating sleep medication doses without documented medical evaluation
- Insomnia attributed to “stress” without assessment for depression/anxiety
- Multiple medication trials without a documented reason for changes
- Sleep disturbance attributed to insomnia, but symptoms suggest apnea
The applicant takingtheĀ initiative to identify and treat underlying causes receives much better underwriting consideration than the applicant treating insomnia as an isolated problem.
Sleep Medication and Underwriting Impact
Key insight: Sleep medication use itself doesn’t disqualify you from life insurance or dramatically increase rates, but underwriters evaluate medication appropriateness, dosage trends, and whether the medication is actually working.
Sleep medications are commonāapproximately 9 million Americans use prescription sleep aids annually. Underwriters recognize insomnia medication as a legitimate treatment when used appropriately. However, certain patterns raise underwriting concerns.
Medication Categories and Underwriting
Benzodiazepines (Valium, Xanax, Ativan)
- Underwriting concern: Moderate to high; dependency risk, respiratory depression risk
- Acceptable scenarios: Short-term use (under 3 months) for acute insomnia; PRN (as-needed) dosing
- Problematic scenarios: Chronic daily use, escalating doses, long-term use without a discontinuation plan
- Impact on rates: Minimal if short-term; Table B-C if chronic
Non-Benzodiazepine Sedative-Hypnotics (Ambien, Lunesta, Sonata)
- Underwriting concern: Low to moderate; fewer respiratory/dependency concerns than benzos
- Acceptable scenarios: Chronic use at stable doses; documented good response
- Problematic scenarios: Rapid dose escalation, frequent medication changes, unclear efficacy
- Impact on rates: Usually minimal if stable; Table A-B if dose escalating
Antidepressants (Trazodone, Amitriptyline, Mirtazapine)
- Underwriting concern: Low; off-label sleep use with safety track record
- Acceptable scenarios: Sleep is a secondary benefit; primary indication (depression/anxiety) being treated
- Problematic scenarios: Using antidepressants only for sleep without addressingtheĀ primary indication
- Impact on rates: Minimal; depended on underlying condition being treated, not medication
Melatonin and Over-the-Counter Sleep Aids
- Underwriting concern: Very low; demonstrates conservative approach to treatment
- Acceptable scenarios: All scenarios with OTC options; indicates preference for non-prescription approach
- Problematic scenarios: None significant; occasional use viewed positively by underwriters
- Impact on rates: None; no rate impact
Red Flag Medication Patterns
Patterns That Trigger Underwriting Concerns
- Rapid escalation: Starting dose doubled or tripled within 6 months; suggests developing tolerance or worsening insomnia
- Frequent changes: Multiple medication switches in a short timeframe; suggests inadequate efficacy or side effects
- Polypharmacy: Taking 3+ medications for sleep; suggests complex case or medication mismanagement
- Prescribers jumping: Different doctors prescribing different sleep medications without documented coordination raises pill-seeking concerns
- No documented response: Medical records showing continued sleep disturbance despite multiple medications
- High-dose benzodiazepine at bedtime: Particularly concerning for accident risk and overall safety
These patterns suggest either poor medication management, worsening underlying condition, or medication misuseāall underwriting red flags.
Professional Insight
“The medication itself rarely drives underwriting decisions in insomnia cases. What matters is: Is this medication dose stable? Is it working? Is the prescriber being logical about the approach? Someone on a stable dose of Lunesta that’s helping them sleep gets standard rates. Someone who’s been through six different sleep medications in a year, with escalating doses and no clear benefit, gets table ratings or postponement because something isn’t right with either the diagnosis or the management.”
– InsuranceBrokers USA – Management Team
Sleep Study Results and Medical Documentation
Key insight: A normal sleep study is one of the most powerful underwriting documents in insomnia cases. The absence of a sleep study when symptoms suggest apnea risk is a major red flag that typically results in postponement.
Sleep studies (polysomnography) measure multiple physiological parameters during sleep: brain waves, eye movement, muscle tone, heart rate, breathing effort, oxygen saturation, and limb movements. Results distinguish between primary insomnia and sleep-disordered breathing.
Sleep Study Results Interpretation
Normal Sleep Study
- Apnea-Hypopnea Index (AHI): 0-5 events/hour (normal)
- Oxygen saturation: Remains above 95% throughout the night
- Sleep architecture: Normal sleep stages; adequate REM and deep sleep
- Arousals: Normal frequency, typically related to sleep onset
- Underwriting impact: Very positive; confirms primary insomnia, rules out apnea
Mild Sleep Apnea
- AHI: 5-15 events/hour
- Oxygen drops: Brief desaturations but typically above 92%
- Sleep fragmentation: Increased arousals; sleep architecture disrupted
- Treatment needed: CPAP or BiPAP is typically recommended
- Underwriting: Requires treatment compliance documentation
Moderate to Severe Sleep Apnea
- AHI: 15+ events/hour
- Oxygen drops: Significant desaturations, sometimes below 85-90%
- Sleep quality: Severely fragmented; minimal restorative sleep
- Cardiac stress: Documented arrhythmias or significant blood pressure swings
- Underwriting: Major concern; requires aggressive treatment and compliance
CPAP/BiPAP Compliance Documentation
Critical for Sleep Apnea Cases
If you’ve been diagnosed with sleep apnea and prescribed positive airway pressure (PAP) therapy, compliance documentation is essential for underwriting:
- Device data cards: Download compliance data from CPAP/BiPAP showing nightly usage hours and therapy effectiveness
- Target: Minimum 4-6 hours per night, 5-7 nights per week is typical “good compliance”
- Duration: Documented compliance for at least 3-6 months strengthens the application
- Recent follow-up: Sleep specialist appointment confirming continued device use and symptom improvement
- Follow-up sleep study: If available, repeat sleep study showing normalized AHI on therapy is the gold standard
PAP therapy compliance is the difference between Table ratings and standard rates for sleep apnea cases.
Home Sleep Apnea Test (HSAT) vs. In-Lab Study
In-Laboratory Polysomnography (Gold Standard)
What it is: Full overnight study in a sleep lab with EEG, EOG, EMG, heart rate, breathing, and oxygen saturation monitoring
Underwriting value: Highest; complete data with no technical limitations
Cost: Higher ($1,500-3,000)
Time: One night (results available in 1-2 weeks)
Home Sleep Apnea Test (HSAT)
What it is: Portable device measuring airflow, breathing effort, oxygen saturation (not EEG/sleep stages)
Underwriting value: Good if positive; if negative, an in-lab study may still be recommended if clinical suspicion is high
Cost: Lower ($300-800)
Time: Patient performs at home; results in 1 week
Limitation: Cannot detect central apnea or complex sleep patterns; may miss mild apnea
ā ļø Missing Sleep Study Red Flag
If you report symptoms suggesting sleep apnea (excessive daytime sleepiness, witnessed apneic episodes, loud snoring, morning headaches) but have never had a sleep study, expect underwriters to either:
- Request sleep study completion before approval
- Postpone the application until the study is completed
- Decline the application citing inadequate evaluation
Having a sleep study done before applying significantly strengthens your application and avoids these delays.
Strengthening Your Application: Documentation Strategy
Key insight: Comprehensive medical documentation demonstrating appropriate sleep evaluation, clear diagnosis, and stable effective treatment is far more powerful than simply reporting insomnia symptoms.
Successful applications from people with insomnia share common documentation elements: evidence of professional sleep evaluation, clear diagnosis, documented treatment efficacy, and absence of concerning patterns (medication escalation, frequent changes, untreated underlying conditions).
Essential Documentation Components
Comprehensive Application Documentation for Insomnia
- Sleep history timeline: When insomnia started, what triggered it, whether it’s chronic or episodic
- Sleep study results: If completed, include full report with AHI, oxygen saturation data, and interpretation
- Current sleep medication: Specific medication names, doses, frequency, duration on current regimen
- Medication history: Previous sleep medications tried and the reason each was discontinued (tolerance, side effects, efficacy)
- Sleep specialist evaluation: If seen by a sleep medicine specialist, include their assessment and recommendations
- Recent medical records: Primary care or sleep specialist visit notes showing current sleep status assessment
- Underlying conditions documentation: If insomnia is secondary (depression, anxiety, pain, etc.), documentation of treatment for the primary condition
- Behavioral modifications: Evidence of sleep hygiene improvements, cognitive behavioral therapy for insomnia (CBTi), or lifestyle changes attempted
- Physician letter: Comprehensive assessment from treating physician or sleep specialist
- Overall health context: Recent labs showing no metabolic/thyroid abnormalities, if the insomnia etiology investigation suggests the need
The Physician Letter: Essential Elements
What Your Doctor Should Address
Request a comprehensive letter from your primary care physician or sleep medicine specialist covering:
- Insomnia diagnosis: Primary (idiopathic) versus secondary (caused by another condition)
- Symptom description: Difficulty falling asleep, staying asleep, or early morning awakening? Which applies?
- Sleep study status: Has a sleep study been performed? Results if completed
- Sleep apnea assessment: Has apnea been ruled out? Clinical reasoning
- Underlying conditions: Any comorbid conditions (mental health, medical) contributing to insomnia?
- Current treatment: Medication name, dose, duration, response/efficacy
- Treatment history: Previous medications tried and outcomes
- Non-pharmacologic interventions: Behavioral therapy, sleep hygiene modifications, other approaches tried
- Stability assessment: Is the current treatment stable? Is insomnia controlled?
- Overall health trajectory: Is this worsening, stable, or improving?
- Comparative statement: How does this patient’s insomnia compare to typical cases?
Strategic Application Timing
Apply Sooner If:
- You have a normal sleep study (rules out apnea)
- You’ve been on stable sleep medication for 6+ months
- Your insomnia is well-controlled with the current treatment
- You’ve been evaluated by a sleep specialist
- Underlying conditions causing insomnia are managed
Consider Waiting If:
- You haven’t had a sleep study (get one first)
- You recently started sleep medication (wait 3-6 months for stability)
- You just had a medication change (let the new regimen stabilize)
- Underlying anxiety or depression is actively being treated
- Your sleep is poorly controlled (optimize treatment first)
ā ļø Documentation Mistakes to Avoid
- No sleep study: For anyone with risk factors, a missing sleep study is a major red flag
- Vague physician letter: “Patient has insomnia” isn’t sufficient; need detailed assessment addressing apnea risk and underlying conditions
- Medication escalation pattern: If doses have doubled or tripled, be prepared to explain why
- Multiple medication switches: Document reason for each change; appears random without explanation
- Unaddressed underlying condition: Mentioning depression/anxiety without showing it’s being treated raises concerns
- Old documentation: Records over 6 months old may need updating; current status matters
- No response to current treatment: If documentation shows continued poor sleep despite medication, the application faces headwinds
Rate Classifications and Premium Examples
Key insight: Most people with insomnia receive standard or near-standard rates. Significant table ratings are typically reserved for cases with untreated sleep apnea, uncontrolled mental health conditions, or unstable medication regimens, not insomnia per se.
Understanding realistic rate expectations helps you recognize fair offers and know when additional quotes might yield better results.
Rating Distribution by Profile
Standard or Preferred Ratings (70% of insomnia applicants)
Profile: Primary insomnia well-controlled
- Normal sleep study (sleep apnea ruled out)
- Stable sleep medication at the same dose for 6+ months
- Insomnia well-controlled; minimal daytime impairment
- No underlying untreated mental health conditions
- No comorbid medical conditions worsening sleep
Rate impact: Same as general populationāno insomnia penalty
Table A-B Ratings (15% of insomnia applicants)
Profile: Insomnia with minor complexities
- Sleep apnea diagnosed and well-controlled with PAP therapy
- Insomnia with managed anxiety or depression
- Recent medication change, but stable on new regimen
- Mild daytime sleepiness but manageable with treatment
Rate impact: +15% to +50% premium
Table C-E Ratings (10% of insomnia applicants)
Profile: More complex insomnia cases
- Sleep apnea with questionable PAP compliance
- Insomnia with an uncontrolled mental health condition
- Escalating medication doses or frequent changes
- Multiple failed treatment attempts
Rate impact: +50% to +150% premium
Table F+ or Postponement (5% of insomnia applicants)
Profile: Complex cases requiring specialist review
- Untreated sleep apnea (no evaluation performed)
- Insomnia with an uncontrolled serious mental health condition
- Medication mismanagement or pill-seeking patterns
- Severe daytime impairment despite treatment
Action: Typically, postponement pending better control or specialist carrier evaluation
Premium Examples by Profile
Sample Rate Comparison: 45-Year-Old, $500,000 20-Year Term
| Insomnia Profile | Documentation | Rating Class | Annual Premium | Monthly Cost |
|---|---|---|---|---|
| Well-controlled primary insomnia, normal sleep study | Sleep study normal, stable medication 6+ months | Standard | $585 | $49 |
| Mild sleep apnea, compliant with CPAP | Sleep study showing AHI 8, CPAP use 5+ hrs/night | Table A | $725 | $60 |
| Insomnia with managed anxiety | Normal sleep study, stable on anxiety + sleep meds | Table A | $745 | $62 |
| Moderate sleep apnea, PAP non-compliant | Sleep study AHI 22, CPAP use documented as poor | Table D | $1,125 | $94 |
| Severe insomnia, multiple medication trials | Sleep study pending, escalating medications, and ongoing adjustment | Postponed | N/A | N/A |
Rates are estimates for illustration only. Actual premiums vary by carrier, age, health factors, and individual circumstances.
When to Accept an Offer vs. Shop for Better Rates
Accept the Offer When:
- Rate matches examples above for your profile
- You have documented a normal sleep study
- You’ve received multiple quotes with similar results
- You need coverage and don’t anticipate improvement soon
- Current treatment is stable and working
Consider Shopping When:
- Rating seems worse than your profile justifies
- You just completed a sleep study with normal results
- You recently started a stable medication regimen
- You’ve gotten sleep apnea under control with PAP
- You’ve only contacted one carrier
Coverage Options by Severity and Treatment Status
Key insight: Most people with insomnia qualify for standard fully-underwritten insurance. Alternative options are primarily relevant for those with very severe, treatment-resistant insomnia or comorbid conditions that complicate underwriting.
The insomnia pathway to coverage differs significantly based on whether you have a documented sleep study and whether sleep apnea has been ruled out.
Standard Underwritten Coverage (Typical Path)
Who It’s Best For
- Primary insomnia with normal sleep study
- Sleep apnea was diagnosed and treated with PAP compliance
- Stable, well-controlled insomnia on current treatment
- No significant daytime impairment or safety concerns
Process: Standard application, possible sleep study request if not completed, full medical underwriting
Coverage available: Up to $1-5M+
Products: Term life insurance (10, 20, 30-year), whole life, universal life
Simplified Issue Insurance
When to Consider
- Insomnia is well-controlled, butIĀ don’t want a medical exam
- Need faster underwriting (24-72 hours typical)
- Moderate coverage needs ($50K-500K)
- Don’t have recent documentation readily available
Coverage Details
- Coverage: $50,000-$500,000 typically
- Health questions: Limited (don’t typically ask specifically about insomnia)
- Rate impact: Slightly higher than standard, but often worth it for speed
- See our simplified issue insurance guide
No Medical Exam Insurance
When and How to Use This
No-exam policies focus on health questions rather than medical evaluation:
Best for:
- Insomnia that’s stable and doesn’t limit daily function
- Quick coverage needs
- Ages 45-65 with modest coverage amounts
- Bridge coverage while full underwriting processes elsewhere
Coverage: $25,000-$500,000
Timing: Approval typically 1-2 weeks
Cost: Rates higher than exam-required, but often reasonable
Group Life Insurance Through Employers
Valuable Bridge Coverage
If your employer offers group life insurance, it’s often a valuable resource:
- Guaranteed issue: Basic coverage (typically 1-3x salary) with no health questions
- Insomnia irrelevant: No health underwriting for guaranteed amount
- Cost: Employer usually subsidizes; employee cost is minimal
- Supplemental coverage: Can layer individual policies on top for greater protection
- Limitation: Coverage ends if employment terminates
Layer employer coverage with an individual policy for complete protection while managing costs.
Guaranteed Issue Insurance
When All Else Fails
Guaranteed issue policies accept all applicants regardless of health:
Best for:
- Severe, treatment-resistant insomnia with daytime impairment
- Insomnia complicated by multiple untreated conditions
- Declined by all other carriers
- Need immediate coverage regardless of underwriting complexity
Coverage details:
- Amount: $5,000-$25,000 (modest coverage)
- Graded death benefit: Full benefit after 2-3 years (accidental death immediate)
- Cost: High premiums reflecting acceptance without underwriting
- Purpose: Final expense coverage, not major income replacement
- See our final expense insurance guide
Frequently Asked Questions
Will insomnia disqualify me from life insurance?
No. Insomnia is extremely commonāapproximately one-third of Americans experience itāand underwriters recognize it as a manageable condition. Insomnia alone doesn’t disqualify you from coverage or automatically increase rates. What underwriters evaluate is: (1) Have you been assessed to rule out sleep apnea? (2) Are any underlying mental health or medical conditions being managed? (3) Is your current treatment stable? When these are addressed appropriately, most people with insomnia receive standard or near-standard rates.
Do I need a sleep study before applying for life insurance?
If you have symptoms suggesting sleep apnea (excessive daytime sleepiness, witnessed apneic episodes, loud snoring, morning headaches), underwriters will likely request a sleep study before making an underwriting decision. If you haven’t had one already, you can either: (1) complete the sleep study before applying, which strengthens your application, or (2) apply and expect potential postponement pending sleep study completion. A normal sleep study is one of the most powerful underwriting documents you can provide in insomnia cases because it definitively rules out sleep apnea.
How does sleep apnea affect life insurance underwriting?
Sleep apnea significantly impacts underwriting because untreated apnea increases cardiovascular mortality risk. Mild apnea that’s diagnosed and treated with CPAP/BiPAP (with documented compliance) can receive standard to Table B ratings. Untreated apnea or non-compliant treatment faces table ratings or postponement. Severe apnea with poor compliance may result in a decline. This is why underwriters prioritize sleep study resultsāthey need to know whether apnea exists and, if so, whether it’s being managed.
Can I get standard life insurance while taking sleep medication?
Yes, absolutely. Sleep medication use doesn’t disqualify you from standard rates. What matters is: Is the medication working? Is the dose stable? Is it being prescribed appropriately? Someone on a stable dose of a sleep aid that’s helping them get good sleep typically receives standard rates. Someone whose doses have been escalating, who’s cycling through multiple medications, or who isn’t actually sleeping well despite medication faces table ratings or postponement. Stability and efficacy matter; medication use per se doesn’t.
What if my insomnia is caused by anxiety or depression?
In this scenario, the underlying mental health condition is the primary underwriting concern, not the insomnia per se. See our anxiety guide and depression guide for comprehensive underwriting information. The good news: if your underlying condition is being appropriately treated and your insomnia is improving as a result, underwriters typically view this favorably. Active treatment of the root cause demonstrates responsible health management.
Can I get life insurance if I’m still trying different sleep medications?
If you’re actively in the medication-adjustment phase, expect underwriters to postpone your application until your regimen stabilizes. Once you’ve been on a consistent medication at a stable dose for 3-6 months with good response, you’re in a much better position to apply. Applying during active medication changes typically results in postponement because underwriters can’t assess whether the treatment is actually working. The strategic approach: optimize your sleep treatment first, then apply when you’re stable.
What about over-the-counter sleep aids like melatonin?
Over-the-counter sleep aids have minimal underwriting impact. Using melatonin, valerian, or other natural sleep aids may actually be viewed positively by underwriters because it demonstrates a conservative approach to treatment. If you’re managing insomnia with OTC options, there’s typically no rate impact. If you’ve tried OTC options and needed to move to prescription medication, that’s a normal progression that underwriters understand and expect.
Will I need to disclose my insomnia history on my insurance application?
Yes. Insurance applications ask about sleep disorders and insomnia history because this is relevant medical information. Honesty is essentialāattempting to hide an insomnia history creates a misrepresentation risk that can void your policy. However, disclosing an insomnia history with proper documentation (sleep study ruling out apnea, stable medication, well-controlled condition) results in standard rates for most applicants. Full disclosure with supporting documentation is far superior to hiding information.
Is there an age at which insomnia affects life insurance more?
Insomnia becomes slightly more underwriting-relevant as you age (55+) because undiagnosed sleep apnea becomes more common and carries a higher cardiovascular risk. However, for applicants of any age, the critical factors are the same: have you been evaluated for apnea? Is any underlying condition being managed? Is your insomnia controlled? A 30-year-old with undiagnosed sleep apnea faces greater underwriting concern than a 65-year-old with documented primary insomnia that’s well-managed. Age matters less than whether sleep apnea has been ruled out.
Can I qualify for the best life insurance companies with an insomnia history?
Yes, most major insurers have experience underwriting insomnia cases and aren’t automatically concerned. What matters is a carrier-specific approach to insomnia underwriting and how your specific case is evaluated. Some carriers are more conservative with sleep disorders; others are routinely accommodating of primary insomnia with normal sleep studies. Working with an insurance professional who knows carrier-specific guidelines helps you get placed with carriers most likely to view your case favorably.
Ready to Secure Coverage Despite Insomnia?
Insomnia doesn’t disqualify you from life insuranceāmost people with sleep disorders receive standard or near-standard rates when their condition is properly evaluated and managed. Our team specializes in placing insomnia cases with carriers who understand the distinction between primary insomnia and sleep apnea, and who view documented sleep studies and stable treatment favorably. We handle the documentation strategy and carrier selection so you get approved at fair rates.
Free confidential consultation – All consultations are HIPAA compliant
